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ABSTRACT




 nanoparticles consisting of a spherical core of 




 composite structures such as 
“core-shell” will allow combining magnetic controllability of the magnetite core with bactericidal and bac-
teriostatic properties of the silver shell. This effect is very interesting from the perspective of using particles 
with the “core-shell” structure in pharmacy and medicine to create new medicines.
MATERIALS AND METHODS: The study subject is magnetite with the islet silver coating obtained by 
the original single-phase method of chemical co-precipitation with the temperature increasing up to 60–
70°C. The studies were conducted by the following methods: X-ray analysis, semi-quantitative phase anal-
ysis using the program Match!, scanning electron microscopy. The specific surface area of the samples was 
determined by thermal desorption of argon, magnetic characteristics were also determined.
RESULTS AND CONCLUSIONS: In the diffraction pattern the silver peaks at 44.6°, 52° and 76.65° were 
registered, while magnetite peaks did not disappear. It may indicate the islet surface of the magnetic cores. 
The ratio of the phases is confirmed by the data of the semi-quantitative phase analysis. According to the 
data of scanning electron microscopy the average particle sizes of the samples obtained were determined. 

















one has a slightly larger specific surface area. Magnetization of saturation for the sample of an uncoated 
magnetite is 67.5 emu/g, for the sample with a silver coating it is 62.5 emu/g.
Keywords: synthetic modified magnetite, nanoparticles, composite magnet system, silver shell
INTRODUCTION
At the stage of intensive development of 
modern pharmacy, biology and medicine the 
technologies for obtaining nanoparticles are ac-
tively investigated and the magnetic properties 
of nanosystems finding a variety of applications 
are studied (1). Advances in nanotechnology is the 
basis for development of interdisciplinary fields of 
nanoscience. Physical and chemical effects that oc-
cur in the nanoobjects are underlying determinants 
for nanopharmacy, nanobiology, nanochemistry, 
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nanomedicine, nanophysics, nanoelectronics, nano-
technology-based photonics, etc. This is due to the 
fact that obtaining and studying such small objects 
is possible only when combining achievements and 
methods of different scientific disciplines.
In recent years a substantial progress has been 
made in obtaining micro- and nanoparticles, both 
monocomponents (2) and composites on their basis 
with predetermined size, shape and sometimes struc-
ture, for a wide range of compositions of composites 
with the complex structure (3), or by the “core-shell” 
type (4). An advantage of the latest is increase of 
the thermal and chemical stability, decrease of 
cytotoxicity, the possibility of addition of other 
molecules and functional groups, and the shell 
itself prevents oxidation of the basic material (5).
In order to produce magnetic nanoparticles 
with new properties their surface is modified with 
organic or inorganic materials (polymers, biomole-
cules, silica, metals, etc.) giving nanocomposites of 
the “core-shell” type (6,7).
By modifying the surface of nanoparticles with 
a shell having active functional groups, they can be 
linked up to different biological objects (8). Introduc-
tion of composites of this type is a crucial task, which 
allows to solve a number of conceptual problems as-
sociated with diagnosing of cancer (9–11), obtain-
ing magnetically controlled containers for targeted 
drug delivery to target cells (12–16), creating medi-
cal nanorobots that are capable to eliminate defects 
in the body of a sick person (17–19), developing bio-
compatible nanomaterials of a wide range of applica-
tion, materials with antimicrobial, antiviral and anti-
inflammatory activity (20,21), X-ray contrast agents 
for MRT (22), etc.
The preparative methods of synthesis of mag-
netite particles with Au-shell (23), and formation of 
colloidal silver particles (24) are known from the lit-
erature, but considerable attention is drawn to sim-
ilar composite particles partially or completely cov-
ered with silver.
Modification of the surface of the magnetite by 
silver results in appearing bactericidal and bacterio-
static properties of the system and allows to avoid 
the use of a stabilizer (25) because it is the role of the 
silver coating. The ability to promote the regenera-
tion of damaged tissues, destruction of old and can-
cer cells, normalization of inflammatory processes, 
destruction of bacteria (26), viruses, fungi, etc. (27), 
is due to the advantage of silver over many modern 
chemotherapeutic agents.
The known methods for obtaining nanosys-
tems of the “core-shell” type have some drawbacks 
(28–30): the use of little accessible and relatively ex-
pensive polymers, time-consuming synthesis and its 
multistaging. The loss of magnetic properties due to 
stabilization and full cover significantly reduces the 
prospects of further use of the product as a magneto-
carrier (31,32).
The aim of the work was to optimize the pro-





composite of the “core-shell” type with the islet cover 
with preservation of the magnetic properties.
MATERIALS AND METHODS









O, 25% aqueous ammo-
nia, argentum nitrate AgNO
3
 were used in our study. 
Glucose was chemically pure.
The X-ray analysis was performed for identifi-
cation of substances, qualitative phase analysis and 
determination of the composition of the surface lay-
er. Diffraction patterns were recorded on a DRON-
UM1 diffractometer in CoKa radiation of the anode 
line with a graphite monochromator in the reflected 
beam with Bragg-Brentano geometry in the angular 
range of 10-80 degrees in increments of 0.05.
The semi-quantitative phase analysis was per-
formed using the Match! program, version 1.9a. 





composite was determined by scanning electron mi-
croscopy (Tescan Mira 3 LMU), magnification – 500 
000 times.
The specific surface area of the samples was de-
termined by thermal desorption of argon (33). Many 
scientists have already proven that particles with a 
large specific surface become owners of such unique 
properties as increased chemical and biochemical ac-
tivity (34).
To study the magnetic properties a VMP 3000 
vibration magnetometer (the membrane oscillation 
frequency is 70 Hz) at constant magnetic fields with 
the strength up to 150 kA/m was used. Based on the 
data obtained cyclic dependencies of magnetization 
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values on the applied external magnetic field were 
plotted.
Experimental part
The object of the study is magnetite with the 
islet silver coating obtained by the original single-
phase method of chemical co-precipitation with the 
temperature increasing up to 60–70°C.
Magnetite nanoparticles coated with the silver 
islet layer are obtained as follows.
I. Preparation of solutions.
Solution 1. Dissolve the mixture of 13.89 g 









O in distilled water and dilute to 1 l.
Solution 2. Dissolve the calculated mass of 
AgNO
3
 in distilled water to obtain a solution with the 
mass fraction of 0.1%.
Solution 3. Glucose solution with the mass frac-




II. Carrying out the synthesis (the method 
modified by Elmore (35)).
To 1 l of Solution 1 quickly add 25% aqueous 
ammonia solution with a thin jet while stirring vig-





 and creation of pH in the range of 
10–12 (92.32 ml) and subsequent application of the 





To apply the silver coating in 10–15 min add 
successively Solutions 2 and 3 to the solution ob-
tained that is preheated to 40°C while stirring vigor-
ously with a mechanical stirrer. Gradually increase 
the temperature to 60–70°C, keeping the reaction 
mixture for 40 min. The change of a black color of 
the precipitate to light brown indicates completion 
of the reaction. Keep the resulting solution in a con-
stant magnetic field for 24 h, wash with distilled wa-
ter to pH = 9–10, filter on a Buchner funnel and dry 
in the air at room temperature.
RESULTS AND DISCUSSION
The synthetic method proposed provides for-
mation of a colloidal black solution of composite 
nanoparticles, from which in a few minutes the pre-
cipitate of Ag appears on magnetite, and the solution 
becomes brown. Complete bleaching of the solution 
over the precipitate when keeping in a constant mag-
netic field within 24 hours was not observed, indi-
cating the formation of a colloidal solution of the sil-
vered magnetic nanoparticles. Along with the ad-




, its slight 
amount remains in the free state in the form of drop-
lets of about 40 nm. The ability of magnetite to be-
have as a “single drop” (36) provides preservation of 
all silver introduced in the sample.
To develop an effective method of synthesis the 
complex of physical and chemical studies was carried 
out; on their basis the main parameters of the result-
ing nanocomposite were determined.
In the diffraction pattern (Fig. 1) of the mag-
netite sample without the shell (curve 1) the peaks at 
2θ: 21.3°, 35.2°, 41.55°, 50.75°, 63.2°, 67.65°, 74.5° were 
registered; for the magnetite covered with a silver 
coating (curve 2) there were the corresponding peaks 
at 44.6°, 52° and 76.65°, while magnetite peaks did 
not disappear. It may indicate the islet surface, and is 
consistent with the literature data (28,37,38).
The ratio of the phases is confirmed by the data 
of the semi-quantitative phase analysis (Table 1).
According to the data of scanning electron mi-
croscopy the average particle sizes of the samples ob-

































Table 1. The results of semi-quantitative phase analysis
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the average agglomerate size was 3.2 µm. In the case 
of the magnetite with a silver coating the desired 
product was formed immediately as a fine powder 
with the average particle size of 23 nm. It indicates 
the absence of agglomeration since the silver coating 
acts as a stabilizer.














 were obtained on the water 









 (23 nm) were determined. It confirms the 
stabilizing effect of the silver coating in formation of 
colloidal magnetite particles (Fig. 2b).
Magnetite with the silver surface layer com-
pared to the uncovered one has a slightly larger spe-
cific surface area (Table 2), and may indicate reduc-
tion of the particle size (39). The large specific surface 
area increases the area of contact of silvered particles 
with bacteria or viruses, greatly improving its bacte-
ricidal action (40).
Magnetization of saturation for the sample of 
an uncoated magnetite (Fig. 3, curve 1) is 67.5 emu/g, 
for the sample with a silver coating it is 62.5 emu/g 
(Fig. 3, curve 1). This small difference may be due to a 
small area of the covered surface, which changes the 
magnetic parameters.


























Table 2. Results of determination of specific surface










Scripta Scientifica Pharmaceutica, vol. 2, №1, 2015, pp. 53-59 
Copyright © Medical University of Varna   57
Yevgen Levitin, Tеtyana Chan, Oleg Kryskiv et al.
Thus, according to the results of the physical 





 composite obtained by the method proposed 
silver is on the surface of the particles as an islet sur-
face, and partially in the form of inclusions.
The resulting composite has high purity due to 
the shell, which prevents adsorption of ions affecting 
the magnetic properties from solution, and acting as 
a stabilizer makes it possible to avoid agglomeration 
of modified particles. Thanks to the dot coating of 
silver, the greatest advantage is the almost complete 






 composite structures 
of the “core-shell” type improved allows to combine 
the magnetic properties of the core with the bacteri-
cidal and bacteriostatic properties of the shell. The 
totality of these properties offers great opportunities 
for their further use in pharmacy and medicine. 
The key advantages of the synthetic method 
proposed are as follows:
1. The use of ammonia hydrate as a precipita-
tor allows precipitating magnetite more com-
pletely (the yield is 90 – 95%).
2. The synthesis of the magnetic carrier and its 
subsequent covering with the silver shell are 
carried out by the one-pot method.
3. The reaction occurs at a temperature of 60 
– 70°C, and it makes possible to reduce the 
time of the experiment.
4. Coating thickness provides to preserve the 
magnetic properties while providing bacteri-
cidal and bacteriostatic properties. 
5. The method proposed does not involve stabi-
lization of magnetite, which affects the mag-
netic parameters of the desired product.
6. Keeping the sample in a constant magnet-
ic field allows to precipitate particles quick-
ly and to wash several times with distilled 
water.
CONCLUSIONS






with a spherical core and silver islet shell has 
been developed; it allows to obtain modified 
particles of the required size.
2. For the first time the systematic data about 
the effect of conditions of the synthesis on the 





have been obtained; the optimal ratio of the 
components of the nanocomposite and the 
temperature control for the single-phase syn-
thesis have been determined.
3. It has been found that in this composite silver 
is on the surface of magnetic particles in the 
form of the islet layer and single inclusions.





nanocomposite is to provide more 
precise control of the process and its simplic-
ity, the possibility to obtain particles of the 
given sizes with high magnetic characteris-





 composite structures 
of the “core-shell” type where the core is magnetite 
and the shell is a chemically inert biocompatible met-
al Ag allows combining the useful magnetic proper-
ties of the core with bactericidal and bacteriostatic 
properties of the shell, and it is promising for their 
further use in pharmacy and medicine.
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